Resource Center
Resource Center
This webinar, the second in a two-part series, highlights tools and resources in CHAI’s HIV New Product Introduction Toolkit. The toolkit provides ministries of health and implementing partners with the tools necessary to evaluate the adoption and introduction of new HIV products in their local context. This webinar highlighted two consumption monitoring tools, including: 1)...
Read more
This webinar, the first in a two-part series, guides usage of CHAI’s HIV New Product Introduction Toolkit. The toolkit provides Ministries of Health and implementing partners with the tools necessary to evaluate the adoption and introduction of new HIV products in their local context. The webinar also provides an overview of the CHAI ARV Phase-In/Phase-Out...
Read more
In 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2017 Family Planning Market Report can be found below.
Read more
The HIV/AIDS community received good news ahead of the 2017 International AIDS Society (IAS) meeting in Paris: for the first time ever, more than 50 percent of people living with HIV were receiving antiretroviral therapy (ART) at the end of 2016 and AIDS-related deaths have halved since 2005. If this trend continues, the world will...
Read more
CHAI’s ARV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2016 and outlines CHAI’s expectations on how the market will evolve over the next five years. Read the report here: 2017 ARV Market Report
Read more
The 2016 Annual Report highlights CHAI’s programmatic work around the world, thanks to our many dedicated partners and supporters.
Read moreNegotiated pricing agreements have lowered costs and will improve access to quality treatment for people living with HIV New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries...
Read more
National HIV treatment programs are preparing for big shifts in their national treatment guidelines and patient regimens. The World Health Organization’s (WHO) 2016 guidelines included a number of antiretroviral (ARV) medications that are more effective, tolerable and affordable (some of which are now available), in addition to optimal pediatric formulations which improve upon limited treatment...
Read moreClinton Health Access Initiative, Inc. Policy Update: July 14, 2017 STATEMENT The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives, reducing the burden of disease, and strengthening integrated health systems in the developing world. CHAI areas of focus include HIV/AIDS and TB, Increasing the Efficiency and Effectiveness of...
Read more
As we recognize World Hepatitis Day this year, there is hope for millions of people living with chronic hepatitis around the world. New, directly acting antiviral (DAA) medications are providing a cure to people infected with the disease. In Vietnam, one of the countries with highest rates of hepatitis C (HCV) infection in the world,...
Read more